HIGHLIGHTS
- who: Jie Zhu and colleagues from the University have published the paper: Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials, in the Journal: (JOURNAL)
- what: The aim of this study is to compare the efficacy and safety of neoadjuvant immunotherapy with standard NCRT. Inclusion and exclusion criteria This study was exempted from review by the institutional review board because it only collected published data, and no human subjects were newly enrolled. Subgroup analysis was conducted to investigate the efficacy and safety of different . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.